KELLER, Texas - There is progress toward a COVID-19 vaccine. The Pfizer Phase 3 trial is now approved to include teenagers 16 and older. The trial has surpassed the 30,000 participants originally needed and now expanding to 44,000. As the trial ...
from Google Alert - health https://ift.tt/3iNenoN
via IFTTT
0 comments:
Post a Comment